XOMA Royalty (XOMA) Total Debt Growth (1y) (2011 - 2026)
XOMA Royalty (XOMA) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 103.99% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.84% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | -9.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.50% |
| Dec 31, 2025 | -7.86% |
| Jun 30, 2025 | -5.73% |
| Mar 31, 2025 | -5.83% |
| Dec 31, 2024 | -4.67% |
| Mar 31, 2021 | -40.20% |
| Dec 31, 2020 | -35.40% |
| Sep 30, 2020 | -8.34% |
| Jun 30, 2020 | 19.48% |
| Mar 31, 2020 | 39.62% |
| Dec 31, 2019 | 43.59% |
| Sep 30, 2019 | 48.31% |
| Jun 30, 2019 | 75.20% |
| Mar 31, 2019 | 54.98% |
| Dec 31, 2018 | 54.26% |
| Sep 30, 2018 | 54.08% |
| Jun 30, 2018 | -46.69% |
| Mar 31, 2018 | -45.28% |
| Dec 31, 2017 | -66.24% |
| Sep 30, 2017 | -68.38% |